Balanitis with eczematous perigenital intertriginous candidosis.
Tietz
Hans-Jürgen
HJ
Institut für Pilzkrankheiten, Luisenstr, Berlin, Germany. tietz@institut-fuer-pilzkrankheiten.de
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001446:Balanitis / Q000188:drug therapy* / Q000382:microbiology; D002176:Candida albicans / Q000187:drug effects / Q000302:isolation & purification; D002179:Candidiasis, Cutaneous / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D004060:Diflucortolone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D004485:Eczema / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D005837:Genitalia, Male / Q000382:microbiology / Q000473:pathology*; D006801:Humans; D007402:Intertrigo / Q000188:drug therapy* / Q000382:microbiology; D008297:Male; D008825:Miconazole / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009824:Ointments / Q000008:administration & dosage; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D004338:Drug Combinations; D009824:Ointments; C013486:diflucortolone valerate; C020531:Travocort; D008825:Miconazole; C020382:isoconazole; D004060:Diflucortolone